NEW YORK – Mesa Biotech said on Tuesday that it has received Emergency Use Authorization from the US Food and Drug Administration for its Accula SARS-CoV-2 test.
The PCR test is designed for the qualitative visual detection of nucleic acid from the SARS-CoV-2 virus in combined throat swab and nasal swab specimens from patients suspected by their healthcare provider of having COVID-19.